Can virtual doula sessions and home monitoring prevent preeclampsia in black women?

NCT ID NCT07491510

First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times

Summary

This study will test a telehealth group prenatal care program called Centering HER in 72 low-income, predominantly Black pregnant women in Kansas who are at moderate or high risk for preeclampsia. Participants will receive routine care plus seven doula-led virtual group sessions, a Bluetooth blood pressure cuff and scale, and optionally an Apple Watch. The goal is to see if this program improves blood pressure monitoring and aspirin use, and ultimately reduces early-onset preeclampsia.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

behavioral intervention: telehealth group prenatal care (Centering HER) with doula-led sessions, Bluetooth BP cuff/scale, and optional Apple Watch

What this could lead to

If successful, this program could offer a practical way to reduce early-onset preeclampsia in high-risk, low-income Black women through better monitoring and aspirin adherence.

What could go wrong

This is a small, early feasibility study (72 participants) that has not yet started recruiting. It tests a behavioral program, not a drug, so the impact may be limited and may not apply to other populations or settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIGH BLOOD PRESSURE (& [ESSENTIAL HYPERTENSION]) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

essential hypertension hypertension, pregnancy-induced hypertensive disorder preeclampsia prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Kansas Medical Center

    Kansas City, Kansas, 66101, United States